Sherman Jeffrey W's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Sep 23, 2021
- Accession no.
- 0001209191-21-057450
- Filed
- Sep 23, 2021
- Trade date
- Sep 3-21, 2021
- Filing delay
- 20 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.09M. It was filed 20 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Jeffrey WCIK 0001230482 | Officer (EVP and Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | Ordinary Shares | GGiftDisposed | −4,042 | $0.00 | $0 | 9,115 | Direct | |
| Sep 3, 2021 | Ordinary Shares | GGiftAcquired | +4,042 | $0.00 | $0 | 27,079 | Indirect | |
| Sep 21, 2021 | Ordinary Shares | MOption exerciseAcquired | +46,271 | $7.61 | +$352,122.31 | 55,386 | Direct | |
| Sep 21, 2021 | Ordinary Shares | SSaleDisposed | −46,271 | $110.00 | −$5,089,810 | 9,115 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Ordinary Shares | MOption exerciseDisposed | −46,271 | $0.00 | $0 | 10,729 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.